Antiandrogenic and Antimineralocorticoid Health Benefits of COC Containing Newer Progestogens: Dienogest and Drospirenone

Oncotarget - United States
doi 10.18632/oncotarget.19833
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Newer Progestogens

Journal of Family Planning and Reproductive Health Care
2003English

Effects of a New Oral Contraceptive Containing an Antimineralocorticoid Progestogen, Drospirenone, on the Renin-Aldosterone System, Body Weight, Blood Pressure, Glucose Tolerance, and Lipid Metabolism.

Journal of Clinical Endocrinology and Metabolism
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
1995English

Overview of the Therapeutic Possibilities of Combined Oral Contraceptive Containing Estradiol Valerate and Dienogest

Medical Council
2019English

Is It Ethical to Use Drospirenone-Containing Combined Oral Contraceptives?

Journal of Family Planning and Reproductive Health Care
2012English

Prothrombotic Changes in Users of Combined Oral Contraceptives Containing Drospirenone and Cyproterone Acetate

Journal of Thrombosis and Haemostasis
MedicineHematology
2004English

Drospirenone-Containing Oral Contraceptives and Venous Thromboembolism: An Analysis of the FAERS Database

Open Access Journal of Contraception
2018English

Drospirenone-Containing Oral Contraceptives Do Not Affect Glucose Regulation and Circulating Corticosterone

Journal of Basic and Clinical Physiology and Pharmacology
MedicineDrug DiscoveryPhysiologyPharmacology
2019English

Drospirenone and VTE

Journal of Family Planning and Reproductive Health Care
2010English

Drospirenone and PCOS

Journal of Family Planning and Reproductive Health Care
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy